This filing signals severe financial distress and a high risk of further dilution. The company's core fertility business is shrinking, and its new ventures (digital assets, real estate) are unproven and capital-intensive. Traders should expect continued stock price volatility driven by reverse splits and potential delisting risk. Monitor for any actual pricing of this offering and subsequent dilution, as well as any further Nasdaq compliance notices.
Executive Summary
NewGenIvf Group Ltd filed an amended F-1 registration statement for a best-efforts offering of up to [] Class A Ordinary Shares and [] Pre-Funded Warrants, with no minimum offering amount. The company is a micro-cap ($3M market cap) assisted reproductive services provider undergoing a rapid, high-risk transformation into digital assets (Solana), UAE real estate development, and tokenization services. Revenue declined 13% YoY to $4.73M in FY2025, and the company reported a net income of $9.73M driven by a non-cash $21.65M bargain purchase gain, while core operations generated a $10.73M operating loss. The company has a going concern risk, has executed seven reverse stock splits since Feb 2025, and faces ongoing Nasdaq compliance challenges. The filing also includes a $250K convertible note purchase agreement with Labrys Fund II, L.P., adding to the company's substantial debt and dilution burden.
Key Financial Metrics
Key Facts
- Revenue declined 13.01% YoY from $5.43M (FY2024) to $4.73M (FY2025).
- Net income of $9.73M in FY2025 was driven by a non-cash $21.65M bargain purchase gain; operating loss was $10.73M.
- Cash and cash equivalents were only $758,621 as of Dec 31, 2025, with $9.3M in outstanding convertible notes and $6.46M in unpaid acquisition commitments.
- The company has executed seven reverse stock splits since February 2025 to maintain Nasdaq listing compliance.
- The company has a going concern risk and is undergoing a risky transformation into digital assets, real estate, and tokenization.
- This is a best-efforts offering with no minimum; proceeds are uncertain.
- The filing includes a $250K convertible note purchase agreement with Labrys Fund II, L.P., adding to the company's debt and potential dilution.
Financial Impact
Revenue declined 13% YoY to $4.73M; operating loss of $10.73M; net income of $9.73M was entirely from a non-cash bargain purchase gain. Cash position is critically low at $758,621.
Risk Factors
- Going concern risk with only $758K cash against $9.3M in convertible notes and $6.46M in unpaid acquisition payments.
- Extreme dilution risk from this best-efforts offering, the White Lion equity line, and numerous convertible notes.
- Nasdaq delisting risk due to low market cap and repeated reverse stock splits.
- Business transformation into digital assets and real estate is highly speculative and unproven.
- Revenue decline in core fertility business with no clear path to profitability.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| F-1 Filing (NIVF) — Batch item 1 | 0001213900-26-091922 |
| Document: ea030132501ex10-36.htm | 0001213900-26-091922 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 6-K | $0.1884 $0.1489 | ▼ −20.97% | ▼ −19.79% | $1.46 (+674.95%) |
Oct 7, 2026 19d ago | 6-K | $0.0811 $0.0721 | ▲ +11.10% | ▲ +11.70% | $1.46 (−1700.25%) |
Oct 7, 2026 19d ago | 6-K | $0.1060 $0.0811 | ▼ −23.49% | ▼ −23.07% | $1.46 (+1277.36%) |
Oct 6, 2026 20d ago | SC 13D/A | $0.0987 $0.1060 | ▲ +7.40% | ▲ +7.64% | $1.46 (+1379.23%) |
Oct 5, 2026 21d ago | 6-K | $0.1100 $0.0987 | ▲ +10.27% | ▲ +10.82% | $1.46 (−1227.27%) |
Sep 30, 2026 26d ago | Press Release | $0.1680 $0.1010 | ▲ +39.88% | ▲ +40.06% | $1.46 (−769.05%) |
Sep 30, 2026 26d ago | 424B4 | $5.38 $3.23 | ▲ +39.88% | ▲ +40.06% | $1.46 (+72.84%) |
Sep 29, 2026 27d ago | EFFECT | $0.0720 $0.1680 | ▼ −133.33% | ▼ −133.54% | $1.46 (−1927.78%) |
Sep 28, 2026 27d ago | Press Release | $0.0720 $0.1680 | ▼ −133.33% | ▼ −133.54% | $1.46 (−1927.78%) |
Sep 2, 2026 7w ago | Insider Cluster | $1.21 $1.18 | ▼ −2.48% | ▼ −3.53% | $1.46 (+20.66%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers